Filter posts

If You’ve Had Chickenpox, Shingles Vaccine is Worth a Shot

If you’re an adult living in the United States, there’s a 95-percent chance you’ve had …

“A Transformative Year in Medicine”

2017 will be remembered as an exciting year for biopharmaceutical innovation. Not only did we …

ICYMI: WSJ Editors on “Biotech’s Breakthrough Year”

2017 was an amazing year for biomedical advances, with 46 novel drug approvals, a near …

BIO’s Tom DiLenge Testifies on Biotechnology Innovation Ecosystem before House E&C #SubHealth

At a hearing today held by the House Energy and Commerce Subcommittee on Health on …

Insurers Distort the Facts on Drug Costs … Again

An effort by the Blue Cross Blue Shield Association (BCBSA) to spur a discussion on …

A New Approach to Assessing Value in Health Care

It’s an important and exciting time in the biotech industry. Spending on prescription drugs has …

Jim Greenwood Talks Biotech Innovation With Bloomberg Radio

While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau …

What's Driving Health Care Spending? Hint: Not Drug Costs.

With health care costs an important concern for many Americans, a common misperception is the …

Blaming Pharma Won’t Lower Health Care Costs

This week, the USA Today Editorial Board took aim at the pharmaceutical industry in a new piece: Stop …

A Discussion on Value at #BIF17

In a recent op-ed, BIO President and CEO Jim Greenwood wrote about a promising trend …